Global Doxifluridine Market Research Report 2023

Doxifluridine Market

It is antitumor drug, is the precursor of fluorouracil (5 FU), within the tumor tissue by the effect of pyrimidine nucleoside phosphorylase, converted to free fluorouracil, thereby inhibiting tumor cell biosynthesis of DNA, RNA, shows that its anti-tumor effect. Due to the activity of the enzyme in the tumor tissue compared with normal tissue is high, so the product in tumor converted into 5 - FU speed for selective tumor. For the treatment of breast cancer, gastric cancer, colorectal cancer,

The global Doxifluridine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Doxifluridine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Doxifluridine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Doxifluridine in Antimetabolic Use is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Doxifluridine include Ipsen, Roche, Nippon Kayaku, DSM Nutritional Products AG, Jiangsu Zhengda Qingjiang Pharmaceutical, Tonghua Maoxiang Pharmaceutical, Shandong New Era Pharmaceutical, Anhui Huarun Jinchan Pharmaceutical and Jiangsu Shengdi Pharmaceutical, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Doxifluridine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Doxifluridine.

The Doxifluridine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Doxifluridine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Doxifluridine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Doxifluridine Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Doxifluridine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Injection

1.2.3 Tablets

1.2.4 Capsule

1.3 Market by Application

1.3.1 Global Doxifluridine Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Antimetabolic Use

1.3.3 Hormone

1.3.4 Cancer Drugs

1.3.5 Antibiotic Medicine

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Doxifluridine Market Perspective (2018-2029)

2.2 Doxifluridine Growth Trends by Region

2.2.1 Global Doxifluridine Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Doxifluridine Historic Market Size by Region (2018-2023)

2.2.3 Doxifluridine Forecasted Market Size by Region (2024-2029)

2.3 Doxifluridine Market Dynamics

2.3.1 Doxifluridine Industry Trends

2.3.2 Doxifluridine Market Drivers

2.3.3 Doxifluridine Market Challenges

2.3.4 Doxifluridine Market Restraints

3.1 Global Top Doxifluridine Players by Revenue

3.1.1 Global Top Doxifluridine Players by Revenue (2018-2023)

3.1.2 Global Doxifluridine Revenue Market Share by Players (2018-2023)

3.2 Global Doxifluridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Doxifluridine Revenue

3.4 Global Doxifluridine Market Concentration Ratio

3.4.1 Global Doxifluridine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Doxifluridine Revenue in 2022

3.5 Doxifluridine Key Players Head office and Area Served

3.6 Key Players Doxifluridine Product Solution and Service

3.7 Date of Enter into Doxifluridine Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Doxifluridine Historic Market Size by Type (2018-2023)

4.2 Global Doxifluridine Forecasted Market Size by Type (2024-2029)

5.1 Global Doxifluridine Historic Market Size by Application (2018-2023)

5.2 Global Doxifluridine Forecasted Market Size by Application (2024-2029)

6.1 North America Doxifluridine Market Size (2018-2029)

6.2 North America Doxifluridine Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Doxifluridine Market Size by Country (2018-2023)

6.4 North America Doxifluridine Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Doxifluridine Market Size (2018-2029)

7.2 Europe Doxifluridine Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Doxifluridine Market Size by Country (2018-2023)

7.4 Europe Doxifluridine Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Doxifluridine Market Size (2018-2029)

8.2 Asia-Pacific Doxifluridine Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Doxifluridine Market Size by Region (2018-2023)

8.4 Asia-Pacific Doxifluridine Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Doxifluridine Market Size (2018-2029)

9.2 Latin America Doxifluridine Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Doxifluridine Market Size by Country (2018-2023)

9.4 Latin America Doxifluridine Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Doxifluridine Market Size (2018-2029)

10.2 Middle East & Africa Doxifluridine Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Doxifluridine Market Size by Country (2018-2023)

10.4 Middle East & Africa Doxifluridine Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Ipsen

11.1.1 Ipsen Company Detail

11.1.2 Ipsen Business Overview

11.1.3 Ipsen Doxifluridine Introduction

11.1.4 Ipsen Revenue in Doxifluridine Business (2018-2023)

11.1.5 Ipsen Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche Doxifluridine Introduction

11.2.4 Roche Revenue in Doxifluridine Business (2018-2023)

11.2.5 Roche Recent Development

11.3 Nippon Kayaku

11.3.1 Nippon Kayaku Company Detail

11.3.2 Nippon Kayaku Business Overview

11.3.3 Nippon Kayaku Doxifluridine Introduction

11.3.4 Nippon Kayaku Revenue in Doxifluridine Business (2018-2023)

11.3.5 Nippon Kayaku Recent Development

11.4 DSM Nutritional Products AG

11.4.1 DSM Nutritional Products AG Company Detail

11.4.2 DSM Nutritional Products AG Business Overview

11.4.3 DSM Nutritional Products AG Doxifluridine Introduction

11.4.4 DSM Nutritional Products AG Revenue in Doxifluridine Business (2018-2023)

11.4.5 DSM Nutritional Products AG Recent Development

11.5 Jiangsu Zhengda Qingjiang Pharmaceutical

11.5.1 Jiangsu Zhengda Qingjiang Pharmaceutical Company Detail

11.5.2 Jiangsu Zhengda Qingjiang Pharmaceutical Business Overview

11.5.3 Jiangsu Zhengda Qingjiang Pharmaceutical Doxifluridine Introduction

11.5.4 Jiangsu Zhengda Qingjiang Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.5.5 Jiangsu Zhengda Qingjiang Pharmaceutical Recent Development

11.6 Tonghua Maoxiang Pharmaceutical

11.6.1 Tonghua Maoxiang Pharmaceutical Company Detail

11.6.2 Tonghua Maoxiang Pharmaceutical Business Overview

11.6.3 Tonghua Maoxiang Pharmaceutical Doxifluridine Introduction

11.6.4 Tonghua Maoxiang Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.6.5 Tonghua Maoxiang Pharmaceutical Recent Development

11.7 Shandong New Era Pharmaceutical

11.7.1 Shandong New Era Pharmaceutical Company Detail

11.7.2 Shandong New Era Pharmaceutical Business Overview

11.7.3 Shandong New Era Pharmaceutical Doxifluridine Introduction

11.7.4 Shandong New Era Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.7.5 Shandong New Era Pharmaceutical Recent Development

11.8 Anhui Huarun Jinchan Pharmaceutical

11.8.1 Anhui Huarun Jinchan Pharmaceutical Company Detail

11.8.2 Anhui Huarun Jinchan Pharmaceutical Business Overview

11.8.3 Anhui Huarun Jinchan Pharmaceutical Doxifluridine Introduction

11.8.4 Anhui Huarun Jinchan Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.8.5 Anhui Huarun Jinchan Pharmaceutical Recent Development

11.9 Jiangsu Shengdi Pharmaceutical

11.9.1 Jiangsu Shengdi Pharmaceutical Company Detail

11.9.2 Jiangsu Shengdi Pharmaceutical Business Overview

11.9.3 Jiangsu Shengdi Pharmaceutical Doxifluridine Introduction

11.9.4 Jiangsu Shengdi Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.9.5 Jiangsu Shengdi Pharmaceutical Recent Development

11.10 Shandong Xinqi Pharmaceutical

11.10.1 Shandong Xinqi Pharmaceutical Company Detail

11.10.2 Shandong Xinqi Pharmaceutical Business Overview

11.10.3 Shandong Xinqi Pharmaceutical Doxifluridine Introduction

11.10.4 Shandong Xinqi Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.10.5 Shandong Xinqi Pharmaceutical Recent Development

11.11 Shaanxi Dongtai Pharmaceutical

11.11.1 Shaanxi Dongtai Pharmaceutical Company Detail

11.11.2 Shaanxi Dongtai Pharmaceutical Business Overview

11.11.3 Shaanxi Dongtai Pharmaceutical Doxifluridine Introduction

11.11.4 Shaanxi Dongtai Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.11.5 Shaanxi Dongtai Pharmaceutical Recent Development

11.12 Jilin Aodong Medicine Yanji

11.12.1 Jilin Aodong Medicine Yanji Company Detail

11.12.2 Jilin Aodong Medicine Yanji Business Overview

11.12.3 Jilin Aodong Medicine Yanji Doxifluridine Introduction

11.12.4 Jilin Aodong Medicine Yanji Revenue in Doxifluridine Business (2018-2023)

11.12.5 Jilin Aodong Medicine Yanji Recent Development

11.13 Zhejiang Guobang Pharmaceutical

11.13.1 Zhejiang Guobang Pharmaceutical Company Detail

11.13.2 Zhejiang Guobang Pharmaceutical Business Overview

11.13.3 Zhejiang Guobang Pharmaceutical Doxifluridine Introduction

11.13.4 Zhejiang Guobang Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.13.5 Zhejiang Guobang Pharmaceutical Recent Development

11.14 Zhejiang Haizheng Pharmaceutical

11.14.1 Zhejiang Haizheng Pharmaceutical Company Detail

11.14.2 Zhejiang Haizheng Pharmaceutical Business Overview

11.14.3 Zhejiang Haizheng Pharmaceutical Doxifluridine Introduction

11.14.4 Zhejiang Haizheng Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.14.5 Zhejiang Haizheng Pharmaceutical Recent Development

11.15 Yangtze Pharmaceutical Group

11.15.1 Yangtze Pharmaceutical Group Company Detail

11.15.2 Yangtze Pharmaceutical Group Business Overview

11.15.3 Yangtze Pharmaceutical Group Doxifluridine Introduction

11.15.4 Yangtze Pharmaceutical Group Revenue in Doxifluridine Business (2018-2023)

11.15.5 Yangtze Pharmaceutical Group Recent Development

11.16 Ningbo Tianheng Pharmaceutical

11.16.1 Ningbo Tianheng Pharmaceutical Company Detail

11.16.2 Ningbo Tianheng Pharmaceutical Business Overview

11.16.3 Ningbo Tianheng Pharmaceutical Doxifluridine Introduction

11.16.4 Ningbo Tianheng Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.16.5 Ningbo Tianheng Pharmaceutical Recent Development

11.17 Shanghai Pacific Pharmaceutical

11.17.1 Shanghai Pacific Pharmaceutical Company Detail

11.17.2 Shanghai Pacific Pharmaceutical Business Overview

11.17.3 Shanghai Pacific Pharmaceutical Doxifluridine Introduction

11.17.4 Shanghai Pacific Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.17.5 Shanghai Pacific Pharmaceutical Recent Development

11.18 Shanghai Zhaohui Pharmaceutical

11.18.1 Shanghai Zhaohui Pharmaceutical Company Detail

11.18.2 Shanghai Zhaohui Pharmaceutical Business Overview

11.18.3 Shanghai Zhaohui Pharmaceutical Doxifluridine Introduction

11.18.4 Shanghai Zhaohui Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.18.5 Shanghai Zhaohui Pharmaceutical Recent Development

11.19 Zibo Wanjie Pharmaceutical

11.19.1 Zibo Wanjie Pharmaceutical Company Detail

11.19.2 Zibo Wanjie Pharmaceutical Business Overview

11.19.3 Zibo Wanjie Pharmaceutical Doxifluridine Introduction

11.19.4 Zibo Wanjie Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.19.5 Zibo Wanjie Pharmaceutical Recent Development

11.20 Jiangsu Hengrui Pharmaceutical

11.20.1 Jiangsu Hengrui Pharmaceutical Company Detail

11.20.2 Jiangsu Hengrui Pharmaceutical Business Overview

11.20.3 Jiangsu Hengrui Pharmaceutical Doxifluridine Introduction

11.20.4 Jiangsu Hengrui Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.20.5 Jiangsu Hengrui Pharmaceutical Recent Development

11.21 Hainan General Tongmeng Pharmaceutical

11.21.1 Hainan General Tongmeng Pharmaceutical Company Detail

11.21.2 Hainan General Tongmeng Pharmaceutical Business Overview

11.21.3 Hainan General Tongmeng Pharmaceutical Doxifluridine Introduction

11.21.4 Hainan General Tongmeng Pharmaceutical Revenue in Doxifluridine Business (2018-2023)

11.21.5 Hainan General Tongmeng Pharmaceutical Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Doxifluridine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Injection

    Table 3. Key Players of Tablets

    Table 4. Key Players of Capsule

    Table 5. Global Doxifluridine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Doxifluridine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Doxifluridine Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Doxifluridine Market Share by Region (2018-2023)

    Table 9. Global Doxifluridine Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Doxifluridine Market Share by Region (2024-2029)

    Table 11. Doxifluridine Market Trends

    Table 12. Doxifluridine Market Drivers

    Table 13. Doxifluridine Market Challenges

    Table 14. Doxifluridine Market Restraints

    Table 15. Global Doxifluridine Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Doxifluridine Market Share by Players (2018-2023)

    Table 17. Global Top Doxifluridine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Doxifluridine as of 2022)

    Table 18. Ranking of Global Top Doxifluridine Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Doxifluridine Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Doxifluridine Product Solution and Service

    Table 22. Date of Enter into Doxifluridine Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Doxifluridine Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Doxifluridine Revenue Market Share by Type (2018-2023)

    Table 26. Global Doxifluridine Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Doxifluridine Revenue Market Share by Type (2024-2029)

    Table 28. Global Doxifluridine Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Doxifluridine Revenue Market Share by Application (2018-2023)

    Table 30. Global Doxifluridine Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Doxifluridine Revenue Market Share by Application (2024-2029)

    Table 32. North America Doxifluridine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Doxifluridine Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Doxifluridine Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Doxifluridine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Doxifluridine Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Doxifluridine Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Doxifluridine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Doxifluridine Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Doxifluridine Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Doxifluridine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Doxifluridine Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Doxifluridine Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Doxifluridine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Doxifluridine Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Doxifluridine Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Ipsen Company Detail

    Table 48. Ipsen Business Overview

    Table 49. Ipsen Doxifluridine Product

    Table 50. Ipsen Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 51. Ipsen Recent Development

    Table 52. Roche Company Detail

    Table 53. Roche Business Overview

    Table 54. Roche Doxifluridine Product

    Table 55. Roche Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 56. Roche Recent Development

    Table 57. Nippon Kayaku Company Detail

    Table 58. Nippon Kayaku Business Overview

    Table 59. Nippon Kayaku Doxifluridine Product

    Table 60. Nippon Kayaku Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 61. Nippon Kayaku Recent Development

    Table 62. DSM Nutritional Products AG Company Detail

    Table 63. DSM Nutritional Products AG Business Overview

    Table 64. DSM Nutritional Products AG Doxifluridine Product

    Table 65. DSM Nutritional Products AG Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 66. DSM Nutritional Products AG Recent Development

    Table 67. Jiangsu Zhengda Qingjiang Pharmaceutical Company Detail

    Table 68. Jiangsu Zhengda Qingjiang Pharmaceutical Business Overview

    Table 69. Jiangsu Zhengda Qingjiang Pharmaceutical Doxifluridine Product

    Table 70. Jiangsu Zhengda Qingjiang Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 71. Jiangsu Zhengda Qingjiang Pharmaceutical Recent Development

    Table 72. Tonghua Maoxiang Pharmaceutical Company Detail

    Table 73. Tonghua Maoxiang Pharmaceutical Business Overview

    Table 74. Tonghua Maoxiang Pharmaceutical Doxifluridine Product

    Table 75. Tonghua Maoxiang Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 76. Tonghua Maoxiang Pharmaceutical Recent Development

    Table 77. Shandong New Era Pharmaceutical Company Detail

    Table 78. Shandong New Era Pharmaceutical Business Overview

    Table 79. Shandong New Era Pharmaceutical Doxifluridine Product

    Table 80. Shandong New Era Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 81. Shandong New Era Pharmaceutical Recent Development

    Table 82. Anhui Huarun Jinchan Pharmaceutical Company Detail

    Table 83. Anhui Huarun Jinchan Pharmaceutical Business Overview

    Table 84. Anhui Huarun Jinchan Pharmaceutical Doxifluridine Product

    Table 85. Anhui Huarun Jinchan Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 86. Anhui Huarun Jinchan Pharmaceutical Recent Development

    Table 87. Jiangsu Shengdi Pharmaceutical Company Detail

    Table 88. Jiangsu Shengdi Pharmaceutical Business Overview

    Table 89. Jiangsu Shengdi Pharmaceutical Doxifluridine Product

    Table 90. Jiangsu Shengdi Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 91. Jiangsu Shengdi Pharmaceutical Recent Development

    Table 92. Shandong Xinqi Pharmaceutical Company Detail

    Table 93. Shandong Xinqi Pharmaceutical Business Overview

    Table 94. Shandong Xinqi Pharmaceutical Doxifluridine Product

    Table 95. Shandong Xinqi Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 96. Shandong Xinqi Pharmaceutical Recent Development

    Table 97. Shaanxi Dongtai Pharmaceutical Company Detail

    Table 98. Shaanxi Dongtai Pharmaceutical Business Overview

    Table 99. Shaanxi Dongtai Pharmaceutical Doxifluridine Product

    Table 100. Shaanxi Dongtai Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 101. Shaanxi Dongtai Pharmaceutical Recent Development

    Table 102. Jilin Aodong Medicine Yanji Company Detail

    Table 103. Jilin Aodong Medicine Yanji Business Overview

    Table 104. Jilin Aodong Medicine Yanji Doxifluridine Product

    Table 105. Jilin Aodong Medicine Yanji Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 106. Jilin Aodong Medicine Yanji Recent Development

    Table 107. Zhejiang Guobang Pharmaceutical Company Detail

    Table 108. Zhejiang Guobang Pharmaceutical Business Overview

    Table 109. Zhejiang Guobang Pharmaceutical Doxifluridine Product

    Table 110. Zhejiang Guobang Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 111. Zhejiang Guobang Pharmaceutical Recent Development

    Table 112. Zhejiang Haizheng Pharmaceutical Company Detail

    Table 113. Zhejiang Haizheng Pharmaceutical Business Overview

    Table 114. Zhejiang Haizheng Pharmaceutical Doxifluridine Product

    Table 115. Zhejiang Haizheng Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 116. Zhejiang Haizheng Pharmaceutical Recent Development

    Table 117. Yangtze Pharmaceutical Group Company Detail

    Table 118. Yangtze Pharmaceutical Group Business Overview

    Table 119. Yangtze Pharmaceutical Group Doxifluridine Product

    Table 120. Yangtze Pharmaceutical Group Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 121. Yangtze Pharmaceutical Group Recent Development

    Table 122. Ningbo Tianheng Pharmaceutical Company Detail

    Table 123. Ningbo Tianheng Pharmaceutical Business Overview

    Table 124. Ningbo Tianheng Pharmaceutical Doxifluridine Product

    Table 125. Ningbo Tianheng Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 126. Ningbo Tianheng Pharmaceutical Recent Development

    Table 127. Shanghai Pacific Pharmaceutical Company Detail

    Table 128. Shanghai Pacific Pharmaceutical Business Overview

    Table 129. Shanghai Pacific Pharmaceutical Doxifluridine Product

    Table 130. Shanghai Pacific Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 131. Shanghai Pacific Pharmaceutical Recent Development

    Table 132. Shanghai Zhaohui Pharmaceutical Company Detail

    Table 133. Shanghai Zhaohui Pharmaceutical Business Overview

    Table 134. Shanghai Zhaohui Pharmaceutical Doxifluridine Product

    Table 135. Shanghai Zhaohui Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 136. Shanghai Zhaohui Pharmaceutical Recent Development

    Table 137. Zibo Wanjie Pharmaceutical Company Detail

    Table 138. Zibo Wanjie Pharmaceutical Business Overview

    Table 139. Zibo Wanjie Pharmaceutical Doxifluridine Product

    Table 140. Zibo Wanjie Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 141. Zibo Wanjie Pharmaceutical Recent Development

    Table 142. Jiangsu Hengrui Pharmaceutical Company Detail

    Table 143. Jiangsu Hengrui Pharmaceutical Business Overview

    Table 144. Jiangsu Hengrui Pharmaceutical Doxifluridine Product

    Table 145. Jiangsu Hengrui Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 146. Jiangsu Hengrui Pharmaceutical Recent Development

    Table 147. Hainan General Tongmeng Pharmaceutical Company Detail

    Table 148. Hainan General Tongmeng Pharmaceutical Business Overview

    Table 149. Hainan General Tongmeng Pharmaceutical Doxifluridine Product

    Table 150. Hainan General Tongmeng Pharmaceutical Revenue in Doxifluridine Business (2018-2023) & (US$ Million)

    Table 151. Hainan General Tongmeng Pharmaceutical Recent Development

    Table 152. Research Programs/Design for This Report

    Table 153. Key Data Information from Secondary Sources

    Table 154. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Doxifluridine Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Doxifluridine Market Share by Type: 2022 VS 2029

    Figure 3. Injection Features

    Figure 4. Tablets Features

    Figure 5. Capsule Features

    Figure 6. Global Doxifluridine Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Doxifluridine Market Share by Application: 2022 VS 2029

    Figure 8. Antimetabolic Use Case Studies

    Figure 9. Hormone Case Studies

    Figure 10. Cancer Drugs Case Studies

    Figure 11. Antibiotic Medicine Case Studies

    Figure 12. Doxifluridine Report Years Considered

    Figure 13. Global Doxifluridine Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Doxifluridine Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Doxifluridine Market Share by Region: 2022 VS 2029

    Figure 16. Global Doxifluridine Market Share by Players in 2022

    Figure 17. Global Top Doxifluridine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Doxifluridine as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Doxifluridine Revenue in 2022

    Figure 19. North America Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Doxifluridine Market Share by Country (2018-2029)

    Figure 21. United States Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Doxifluridine Market Share by Country (2018-2029)

    Figure 25. Germany Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Doxifluridine Market Share by Region (2018-2029)

    Figure 33. China Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Doxifluridine Market Share by Country (2018-2029)

    Figure 41. Mexico Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Doxifluridine Market Share by Country (2018-2029)

    Figure 45. Turkey Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Doxifluridine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Ipsen Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 48. Roche Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 49. Nippon Kayaku Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 50. DSM Nutritional Products AG Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 51. Jiangsu Zhengda Qingjiang Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 52. Tonghua Maoxiang Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 53. Shandong New Era Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 54. Anhui Huarun Jinchan Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 55. Jiangsu Shengdi Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 56. Shandong Xinqi Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 57. Shaanxi Dongtai Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 58. Jilin Aodong Medicine Yanji Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 59. Zhejiang Guobang Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 60. Zhejiang Haizheng Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 61. Yangtze Pharmaceutical Group Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 62. Ningbo Tianheng Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 63. Shanghai Pacific Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 64. Shanghai Zhaohui Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 65. Zibo Wanjie Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 66. Jiangsu Hengrui Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 67. Hainan General Tongmeng Pharmaceutical Revenue Growth Rate in Doxifluridine Business (2018-2023)

    Figure 68. Bottom-up and Top-down Approaches for This Report

    Figure 69. Data Triangulation

    Figure 70. Key Executives Interviewed